Célia Fourrier, PhD, is affiliated with the Discipline of Psychiatry at Adelaide Medical School, University of Adelaide, and the Hopwood Centre for Neurobiology at the South Australian Health and Medical Research Institute. Fourrier has published research focused on cognitive function and psychosocial dysfunction in patients with major depressive disorder, including studies on the effects of celecoxib in combination with vortioxetine and the use of the THINC-integrated tool for assessing cognitive deficits. Her work has appeared in Psychiatrist.com between 2018 and 2023.
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
